311 results on '"Fernández-Piqueras, José"'
Search Results
2. Differential molecular response in mice and human thymocytes exposed to a combined-dose radiation regime
3. Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma
4. The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib
5. Transient exposure to miR‐203 enhances the differentiation capacity of established pluripotent stem cells
6. Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL
7. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data
8. Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma
9. SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms
10. Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL
11. The JAK3Q988P mutation reveals oncogenic potential and resistance to ruxolitinib.
12. Data from A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis
13. Data from A Role for Stroma-Derived Annexin A1 as Mediator in the Control of Genetic Susceptibility to T-Cell Lymphoblastic Malignancies through Prostaglandin E2 Secretion
14. Supplementary Figure 1 Legend from A Role for the Fas/FasL System in Modulating Genetic Susceptibility to T-Cell Lymphoblastic Lymphomas
15. Supplementary Figure 3 from A Role for Stroma-Derived Annexin A1 as Mediator in the Control of Genetic Susceptibility to T-Cell Lymphoblastic Malignancies through Prostaglandin E2 Secretion
16. Supplementary Figure 1 from A Role for Stroma-Derived Annexin A1 as Mediator in the Control of Genetic Susceptibility to T-Cell Lymphoblastic Malignancies through Prostaglandin E2 Secretion
17. Data from A Role for the Fas/FasL System in Modulating Genetic Susceptibility to T-Cell Lymphoblastic Lymphomas
18. Supplementary Figure 2 from A Role for Stroma-Derived Annexin A1 as Mediator in the Control of Genetic Susceptibility to T-Cell Lymphoblastic Malignancies through Prostaglandin E2 Secretion
19. Supplementary Figure 1 from A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis
20. Supplementary Table 1 from A Role for Stroma-Derived Annexin A1 as Mediator in the Control of Genetic Susceptibility to T-Cell Lymphoblastic Malignancies through Prostaglandin E2 Secretion
21. Supplementary Table 2 from A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis
22. Supplementary Information, Legends 1-3 from A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis
23. Supplementary Table 4 from A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis
24. Supplementary Table 1 from A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis
25. Supplementary Figure 2 from A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis
26. Supplementary Table 3 from A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis
27. Supplementary Figure Legends 1-3 from A Role for Stroma-Derived Annexin A1 as Mediator in the Control of Genetic Susceptibility to T-Cell Lymphoblastic Malignancies through Prostaglandin E2 Secretion
28. Supplementary Figure 3 from A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis
29. Supplementary Figure 1 from A Role for the Fas/FasL System in Modulating Genetic Susceptibility to T-Cell Lymphoblastic Lymphomas
30. Supplementary Table 1 from A Role for the Fas/FasL System in Modulating Genetic Susceptibility to T-Cell Lymphoblastic Lymphomas
31. SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T‐cell neoplasms
32. A Dual Role for FADD in Human Precursor T-Cell Neoplasms
33. RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas
34. Genetic epistasis in female suicide attempters
35. Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
36. Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway
37. Patterns of Differentially Expressed circRNAs in Human Thymocytes
38. SAT-1 -1415T/C polymorphism and susceptibility to schizophrenia
39. Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression
40. Extensive Genotyping of the BDNF and NTRK2 Genes Define Protective Haplotypes Against Obsessive-Compulsive Disorder
41. Genetically modified mouse models in cancer studies
42. Lack of correlation between DNA copy number and mRNA expression levels ofc-myc in γ-radiation-induced mouse thymic lymphomas by using quantitative real-time PCR
43. Down-regulation of specific miRNAs enhances the expression of the gene Smoothened and contributes to T-cell lymphoblastic lymphoma development
44. Tumor modifier genes
45. A new locus for resistance to γ-radiation-induced thymic lymphoma identified using inter-specific consomic and inter-specific recombinant congenic strains of mice
46. Evidence of a possible epigenetic inactivation mechanism operating on a region of mouse chromosome 19 in γ-radiation-induced thymic lymphomas
47. Association between the T102C polymorphism of the serotonin-2A receptor gene and schizophrenia
48. EPHA7, a new target gene for 6q deletion in T-cell lymphoblastic lymphomas
49. Loss of heterozygosity at the proximal-mid part of mouse chromosome 4 defines two novel tumor suppressor gene loci in T-cell lymphomas
50. More Insights on the Use of γ-Secretase Inhibitors in Cancer Treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.